Table 3.
Awareness of issues related to registration trials, clinical research, and nursing research
| Aware | Not aware | |
|---|---|---|
| 1. Awareness of issues related to registration trials |
|
|
| Registration trials are necessary for drug registration |
401 (88.5%) |
52 (11.5%) |
| Review by institutional review board is mandatory |
194 (42.8%) |
259 (57.2%) |
| CRC support registration trials |
200 (44.2%) |
253 (55.8%) |
| Informed consent is essential for a registration trial |
422 (93.2%) |
31 (6.8%) |
| Refusal of a registration trial causes no disadvantage |
394 (87.0%) |
59 (13.0%) |
| Some registration trials use placebo |
232 (51.2%) |
221 (48.8%) |
| Participants can withdraw anytime |
345 (76.2%) |
108 (23.8%) |
| Reward for participants is prepared in registration trials |
221 (48.8%) |
232 (51.2%) |
| 2. Awareness of issues related to clinical research |
|
|
| Clinical research includes research using labeled drugs |
192 (42.4%) |
261 (57.6%) |
| Review by ethics committee is mandatory |
242 (53.4%) |
211 (46.6%) |
| Governmental ethical guidelines are applied to clinical research |
245 (54.1%) |
208 (45.9%) |
| Institutional registration is mandatory for investigators at Tokushima University Hospital* |
148 (32.7%) |
305 (67.3%) |
| 3. Awareness on issues related to nursing research |
|
|
| Review by ethics committee is mandatory |
370 (81.7%) |
83 (18.3%) |
| Institutional registration is mandatory for nurse investigators at Tokushima University Hospital* | 244 (53.9%) | 209 (46.1%) |
*Concerns the “local” rule at Tokushima University Hospital.